Clinical Trial Update: Pharmacokinetic Trial of Decitabine (Dacogen) Administered as a 3-hour Infusion to Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study evaluating a 3-hour infusion of decitabine in adults with acute myeloid leukemia or myelodysplastic syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• Dacogen (decitabine)

Snippet

Sponsor: Eisai Inc. | Conditions: Leukemia | Phase 1 | Status: COMPLETED | Results posted: 2011-06-22